Synergistic effects of zoledronic acid and doxorubicin in breast cancer models in vivo

被引：0
|
作者：
Ottewell, P. D.
Jones, M.
Coleman, R. E.
Holen, I.
机构：
[1] Univ Sheffield, Sch Med & Biomed Sci, Clin Oncol, Sheffield, S Yorkshire, England
[2] Univ Sheffield, Ctr Stem Cell Res, Sheffield, S Yorkshire, England
来源：
CANCER TREATMENT REVIEWS | 2006年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
62
引用
收藏
页码：S30 / S30
页数：1
相关论文
共 50 条
  • [1] Zoledronic acid (ZOL) in combination with doxorubicin (DOX) has synergistic effects on apoptosis of breast cancer cells (BCCs) in vitro
    Neville-Webbe, HL
    Evans, CA
    Coleman, RE
    Holen, I
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1598 - 1598
  • [2] Combined effects of zoledronic acid and doxorubicin on breast cancer cell invasion in vitro
    Woodward, JKL
    Neville-Webbe, HL
    Coleman, RE
    Holen, I
    [J]. ANTI-CANCER DRUGS, 2005, 16 (08) : 845 - 854
  • [3] Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer
    Ottewell, Penelope D.
    Monkkonen, Hannu
    Jones, Mark
    Lefley, Diane V.
    Coleman, Robert E.
    Holen, Ingunn
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (16) : 1167 - 1178
  • [4] The effects of zoledronic acid and doxorubicin in combination on breast cancer cell invasion in vitro
    Woodward, JKL
    Neville-Webbe, H
    Coleman, RE
    Holen, I
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (07) : 1299 - 1299
  • [5] In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells
    Ural, A. Ugur
    Avcu, Ferit
    Candir, Muhammed
    Guden, Metin
    Ozcan, M. Ali
    [J]. BREAST CANCER RESEARCH, 2006, 8 (04)
  • [6] Evaluation of the molecular mechanisms for the sequence-dependent, synergistic anti-tumour effects of doxorubicin and zoledronic acid in breast cancer.
    Ottewell, P. D.
    Leftey, D., V
    Coleman, R. E.
    Holen, I
    [J]. CANCER RESEARCH, 2009, 69 (02) : 200S - 201S
  • [7] Synergistic Anti-Breast-Cancer Effects of Combined Treatment With Oleuropein and Doxorubicin In Vivo
    Elamin, Maha H.
    Elmahi, Abdelsalam B.
    Daghestani, Maha H.
    Al-Olayan, Ebtesam M.
    Al-Ajmi, Reem A.
    Alkhuriji, Afrah F.
    Hamed, Sherifa S.
    Elkhadragy, Manal F.
    [J]. ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2019, 25 (03) : 17 - 24
  • [8] The combined effects of zoledronic acid (ZOL) and doxorubicin (DOX) on breast cancer cell invasion in vitro
    Woodward, J
    Coleman, R
    Neville-Webbe, H
    Holen, I
    [J]. CANCER TREATMENT REVIEWS, 2005, 31 : S43 - S43
  • [9] Understanding drug-sequence-dependent synergistic induction of apoptosis by zoledronic acid (ZOL) and doxorubicin (DOX) in breast cancer
    Neville-Webbe, HL
    Coleman, RE
    Holen, I
    [J]. CANCER TREATMENT REVIEWS, 2005, 31 : S41 - S41
  • [10] Understanding drug-sequence-dependent synergistic induction of apoptosis by zoledronic acid (ZOL) and doxorubicin (DOX) in breast cancer
    Neville-Webbe, HL
    Coleman, RE
    Holen, I
    [J]. CANCER TREATMENT REVIEWS, 2005, 31 : S28 - S28
12345